| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |